Iodoxamic acid

Iodoxamic acid
Clinical data
Trade names	Endobil
Other names	3-[3-[2-[2-[2-[3-[(3-Carboxy-2,4,6-triiodophenyl)amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid
ATC code	V08AC01 (WHO) ;
Identifiers
	IUPAC name 3-{1-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]-3,6,9,12-tetraoxapentadecan-15-amido}-2,4,6-triiodobenzoic acid;
CAS Number	31127-82-9;
PubChem CID	35740;
DrugBank	DB13539;
ChemSpider	32877;
UNII	NS1Y283HW4;
KEGG	D01312;
ChEMBL	ChEMBL1201324;
CompTox Dashboard (EPA)	DTXSID4057710 ;
ECHA InfoCard	100.045.875
Chemical and physical data
Formula	C26H26I6N2O10
Molar mass	1287.925 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(=O)c(c1I)c(I)cc(I)c1NC(=O)CCOCCOCCOCCOCCC(=O)Nc(c2I)c(I)cc(I)c2C(=O)O;

Chemical compound

Pharmaceutical compound

Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent.^[1] It features both a high iodine content as well as several hydrophilic groups.

References

^ Mützel W, Taenzer V, Wolf R (1976). "Biotransformation of ioglycamic acid, iodoxamic acid and iotroxic acid in man". Investigative Radiology. 11 (6): 598–601. doi:10.1097/00004424-197611000-00018. PMID 1036733.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.